NEWARK, Del, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The market for Single-Use Bioreactors is expected to be worth US$ 18.9 billion by 2033. The market is expected to be worth US$ 4.5 billion by the end of 2023. It is expected to grow at a significant CAGR of 15.4% between 2023 and 2033.
The market for single-use bioreactors is expected to have an absolute monetary opportunity of US$ 14.4 billion during the review period. It was worth US$ 3.9 billion in 2022.
Request a Sample Report to Explore the Single-Use Bioreactors Market Overview Today:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17855
Single-Use Bioreactors do not require the costly and time-consuming cleaning and sterilization processes that traditional stainless-steel bioreactors require. Due to lower personnel, maintenance, and downtime costs, they may be more cost-effective for a few biotech enterprises and research groups.
Single-Use Bioreactors provide greater production scale flexibility. They have is simple to adapt to different batch sizes. As a result, they may enable businesses to respond quickly to changes in demand or research requirements.
Due to the absence of cleaning and sterilization procedures, Single-Use Bioreactors can reduce the amount of time needed for equipment preparation. Additionally, they provide a straightforward setup, which could lead to quicker turnaround times and greater output.
Since Single-Use Bioreactors are thrown away after use, batch contamination is less likely. This is crucial when creating sensitive items such as vaccines, biological products, and cell therapies.
Sustainability and the reduction of environmental impact are issues that the biopharmaceutical sector is growing more concerned about. Single-Use Bioreactors use fewer resources and emit less wastewater than traditional stainless-steel bioreactors. These characteristics are anticipated to make them a more environmentally friendly option.
Development of single-use bioreactor technology has improved performance and output quality. This development is expected to increase technology adoption in the future.
The worldwide biopharmaceutical sector has been growing steadily as more drugs are created and more biologic therapies are approved. This expansion can result in a greater need for bioreactors, particularly single-use systems.
New bioreactors have gained increased acceptance from regulatory agencies including the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) of the United States. This is explained by the advantages and security of using single-use bioreactors in manufacturing processes.
Cross-contamination between batches is unlikely as Single-Use Bioreactors are discarded after usage. This would lessen the likelihood of batch failure caused by contamination and increase the safety of final products.
Key Takeaways from this Market:
- The global single-use bioreactors industry grew at a steady CAGR of 16.7% in the historical period between 2018 and 2022.
- China single-use bioreactors industry is likely to create an absolute dollar opportunity of US$ 3.3 billion in the review period.
- The United Kingdom single-use bioreactors industry is anticipated to top a valuation of US$ 669.9 million by 2033.
- Based on product, the single-use bioreactor systems segment is anticipated to register a CAGR of 15.3% from 2023 to 2033.
- In terms of type, the stirred-tank SUB segment is expected to witness a CAGR of 15.2% in the evaluation period.
“Since no cleaning or validation procedures are required in between batches, single-use bioreactors enable quick batch changes and quick bioprocess start-ups. Biopharmaceutical firms might be able to react to changes in demand quickly owing to their flexibility. They can adjust production schedules further and address unanticipated supply chain issues,” – Says a lead analyst at Future Market Insights (FMI).
Competitive Landscape:
Leading producers of Single-Use Bioreactors might make significant investments in research & development to continuously advance their technology. They can concentrate on improving functionality, scalability, and compatibility with several cell types, enabling more effective and adaptable bioprocessing.
Key companies would frequently collaborate and develop alliances with research institutions, contract manufacturing organizations (CMOs), and biopharmaceutical businesses. These partnerships can make it easier to share technology, co-create unique solutions, and broaden product offerings to cover more uses.
For instance,
- MarqMetrix unveiled its new product, the ‘Single-use BioReactor BallProbe,’ in March 2023. Development of this novel product was motivated by the biopharmaceutical sector’s growing adoption of disposable technology. The business saw the need for solutions that might minimize risks of contamination while also boosting output and cutting costs.
Seize the Opportunity! Analyze Single-use Bioreactors Market Share with Exclusive Discounts: https://www.futuremarketinsights.com/checkout/17855
Top 5 Companies in this Market:
- Applikon Biotechnology BV
- Cellexus Ltd.
- Celltainer Biotech B.V.
- Cesco Bioengineering Co. Ltd.
- Danaher Corporation
Global Market Segmentation:
By Product:
- Single-use Bioreactor Systems
- Single-use Media Bags
- Single-use Filtration Assemblies
- Others
By Type:
- Stirred-tank SUB
- Wave-induced Motion
- Bubble Column
- Others
By End Use:
- CROs & CMOs
- Academic & Research Institutes
- Biopharma & Pharma Companies
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
Single Dose Radiotherapy Services Market Sales: The global single dose radiotherapy services market is expected to attain a valuation of US$ 7.88 billion in 2023 and is projected to reach US$ 16 billion by 2033, expanding at a CAGR of 7.3% during the forecast period.
Alcohol Use Disorder Treatment Market Review: The global alcohol use disorder treatment market garnered a market value of US$ 700 million in 2023 and is expected to accumulate a market value of US$ 1,300 million by registering a CAGR of 6.4% in the forecast period 2023 to 2033
Drug Delivery Technology Market Revenue: The global drug delivery technology market is expected to be valued at US$ 43.9 billion in 2023. Increasing adoption of advanced technology for effectively delivering the drug to the target site is expected to drive overall market growth. The overall demand for drug delivery technology is projected to grow at a CAGR of 12.6% between 2023 and 2033, totaling around 143.5 billion by 2033.
Silent Scan Technology Market Overview: Silent scan technology has been in the news lately, owing to its steady adoption among end-users looking for noise-free MRI scanning procedures. As per Future Market Insight’s analysis, Silent Scan Technology has an installation base in the range of 1% to 3% of the total global MRI machines. The company forecasts the market to grow at an attractive CAGR during the 10 year forecast period of 2016 through 2026
Portable Bioprocessing Bioreactors Market Demand : The portable bioprocessing bioreactors market is anticipated to flourish at a healthy CAGR of 14.6% between 2023 and 2033. The market is expected to hold a market share of US$ 6.75 billion by 2033 while the market is likely to reach a value of US$ 1.73 billion in 2023.
Small-scale Bioreactors Market Growth : According to the recent report by Future Market Insights (FMI) the small-scale bioreactors market size is estimated to stand at US$ 7.71 billion by 2033. Over the forecast period, the market is assessed to trail at a CAGR of 14.8%. For the year 2023, FMI has estimated the market to be worth US$ 1.94 billion.
Vaccines Market Trends: The vaccines market is likely to strengthen its boundaries at an average CAGR of 6.6% during the forecast period. The market is expected to hold a value of US$ 42.7 billion in 2023 while it is anticipated to cross a value of US$ 80.8 billion by 2033.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube
